Pediatrics

Shorter Course of Treatment for CAP in Children Demonstrates Success

November 22, 2022

Article

Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.

Pharmacy Focus: Public Health Matters- Properly Treating Youth, Sexual and Gender Minority Populations

September 29, 2022

Podcast

Confidential care is a topic that is not discussed as frequently in healthcare, although it is extremely important for adolescents and different vulnerable communities.

Study Shows Rates of Type 2 Diabetes in Children Rose During COVID-19 Pandemic

August 30, 2022

Article

Analysis from the Johns Hopkins Children’s Center and University of Colorado indicates that cancellation of sports and a switch to virtual learning likely increased this risk.

Study: Incidence of PASC in Pediatric Individuals Is Rare

August 29, 2022

Article

Analysis shows that myocarditis was the most commonly diagnosed condition associated with pediatric post-acute sequelae of SARS-CoV-2.

Pfizer, BioNTech Announce Updated COVID-19 Vaccine Efficacy Data for Young Children

August 25, 2022

Article

Analysis is based on previously reported data collected in March and April 2022, with the FDA granting emergency use authorization for individuals aged 6 months to 4 years on June 17.

Study: Children Infected With Mild COVID-19 May Still Develop Long Symptoms

August 17, 2022

Article

Investigators from University of Texas Health Science Center at Houston analyze data from individuals aged 5 to 18 years enrolled in the Texas CARES survey.

Stay Up-to-Date on COVID-19 Vaccines for Children, Teens

August 15, 2022

Article

Pharmacists can help familiarize young patients with the vaccinations appropriate for pediatric use.

Pharmacy Focus: Public Health Matters- Interdisciplinary Care Models Bridging the Gap for Equity

July 21, 2022

Podcast

There are many changes that need to be made on multiple levels of healthcare to combat health disparities and equity.

Dupixent Trial Shows Positive Results in Younger Children With Eosinophilic Esophagitis

July 18, 2022

Article

Phase 3 study follows recent approval of the drug for the same condition in individuals aged 12 years and older who weight at least 40 kg.

Study: Tafinlar, Mekinist Combination Improves Efficacy in Children With Low-Grade Glioma

June 21, 2022

Article

Individuals randomized to receive dabrafenib and trametinib had a statistically significant overall response rate of 47% compared with 11% for those who received chemotherapy.